Cosmo Pharmaceuticals N.V. (COPN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.8B |
| Enterprise Value | 1.75B |
| P/E Ratio | -319.97 |
| PEG Ratio | 3.11 |
| Price/Sales Ratio | 12.09 |
| Price/Book Ratio | 2.44 |
| Enterprise/Revenue | 11.6 |
| Enterprise/EBITDA | 171.62 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.03 |
| Operating Margin | -0.05 |
AD
Management Effectiveness
| Return On Assets | -0.01 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 104.85M |
| Revenue/Share | 6.53 |
| Gross Profit | 48.78M |
| EBITDA | 2.36M |
| Net Income | -3.63M |
| Diluted EPS | -0.23 |
Balance Sheet
| Total Cash | 122.66M |
| Total Cash/Share | 7.68 |
| Total Debt | 4.26M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 7.18 |
| Book Value Per Share | 30.61 |
Price History
| 52-Week Change | 20.43 |
| 52-Week High | 129.4 |
| 52-Week Low | 53.4 |
| Moving Average 50 Days | 79.94 |
| Moving Average 200 Days | 85.81 |
Statistics
| Average Volume | 47,814 |
| Shares Outstanding | 17.13M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.1 |
| Trailing Annual Dividend Yield | 2.86 |
| Payout Ratio | -8.99 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
